Heart Disease Clinical Trials in San Diego

Showing 181-200 of 361 trials

Restore EF Observational Study

NCT04648306

A multi-center, prospective, observational, non-interventional single arm, study of the intermediate-term clinical outcomes collected from electronic health records of high-risk patients which have previously undergone standard of care prophylactic Impella support for a non-emergent percutaneous coronary intervention (PCI).

Coronary Artery DiseaseUnstable AnginaAngina, Stable+1 more

Abiomed Inc.406 participantsStarted Sep 2019

Phoenix, Arizona, United States • Tucson, Arizona, United States • Fayetteville, Arkansas, United States +18 more locations

COMPLETEDPhase 3< 1 mile

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

NCT02104817

The study is a randomized, double-blind, placebo-controlled (corn oil), parallel group design that will enroll approximately 13,000 patients with hypertriglyceridemia and low HDL and high risk for CVD to be randomized 1:1 to either corn oil + statin or Epanova + statin, once daily, for approximately 3-5 years as determined when the number of MACE outcomes is reached.

Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

AstraZeneca13,078 participantsStarted Oct 2014

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +681 more locations

Restore EF Observational Study

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Heart Disease Trials in Other Cities

Sleep Disordered Breathing in Acute Congestive Heart Failure

A Study of CK-1827452 Infusion in Stable Heart Failure

Heart Sounds Registry

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

Comparing Rate Response With CLS Versus Accelerometer ICD Settings in Heart Failure Patients With BIOTRONIK CRT-Ds

Heart Exercise And Resistance Training - Peer Lead ActivitY

Safety and Efficacy Between the Distal and Proximal Radial Vascular Access Technique

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

St. Jude Medical Product Longevity and Performance (SCORE) Registry

Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

Rheos System for the Treatment of HFpEF Heart Failure

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

Randomized Endo-Vein Graft Prospective

Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event

Other Conditions in San Diego